News and Events Careers Resources
ABOUT US
About USpharma
USpharma is a commercial-stage nutraceutical and pharmaceutical company focused on developing and commercializing brand and pharmaceutically-equivalent products for both the consumer health and prescription markets. With industry-leading product development and manufacturing expertise, we are dedicated to providing quality healthcare products to consumers and patients.
Delivering Scientific Solutions that are Reshaping Health and Wellness
At USpharma, our mission is to enhance the health and well-being of consumers through innovative pharmaceutical products. We strive for excellence in every aspect of our operations, from product development to manufacturing. Our dedication to quality ensures that our soft-chew medicines meet the highest standards of safety and efficacy, enabling us to build trust with our customers and stakeholders alike. We believe in integrity, accountability, and the continuous improvement of our processes and products; USpharma is committed to delivering revolutionary health solutions.
Our Facilities
Our state-of-the-art facilities in the US exemplify our commitment to quality and innovation in pharmaceutical manufacturing. Our primary facility, located in Miami Lakes, FL consists of:
-
110 Employees
-
Fully-secured three-building campus, including office space, production, lab, training and warehouse space
-
Over 150,000 sq. ft. cGMP manufacturing facility
-
2 FDA and DEA inspected facilities
-
Major Pharma Quality Systems
-
Major equipment and infrastructure upgrades of over $20 million, including state-of-the-art transdermal manufacturing, heavy power, HVAC, warehouse, cafeteria, and fire system
-
ERP, QMS, DEA vaults, and full-service labs
USpharma works with high-quality CDMO partners located in the United States, Taiwan, and India. Please contact us to learn more about partnership opportunities.
Manesh Dixit, Ph.D.
President, CEO, and Chairman
Dr. Dixit brings 25+ years of experience in the pharmaceutical industry, holding positions of increasing levels of responsibility. He has held executive-level positions in R&D and manufacturing of generic solid dosage products. Dr. Dixit has expertise in the field of transdermal and oral controlled release products including biopharmaceuticals, preformulation, formulation, scale-up, validation, manufacturing, QA, and logistics. He also holds several patents/applications in the area of modified release dosage form design.
Gregory Rocklin
Chief Business Officer
Greg has 30+ years of industry experience in corporate and business development roles. He previously held leadership positions with pharmaceutical firms Watson (Teva), Lupin, Codexis, and Exela.
Greg holds degrees in Pharmacology (B.S.) and Business Economics (M.A.).